about
The functions of the thymus system and the bursa system in the chickenBloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patientsThe fundamental contribution of Robert A. Good to the discovery of the crucial role of thymus in mammalian immunityThe molecular pathology of primary immunodeficienciesClinical Experience with Octagam® 10 %, a solvent detergent virus inactivated intravenous immunoglobulin: a Canadian retrospective review of utilizationSubcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathiesThe Production Processes and Biological Effects of Intravenous ImmunoglobulinHuman genetic basis of interindividual variability in the course of infectionInduction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate ImmunityHealth-related quality of life in patients with primary immunodeficiency diseaseHumoral immunodeficiency : awareness for better supportChronic granulomatous diseaseManufacture of immunoglobulin products for patients with primary antibody deficiencies - the effect of processing conditions on product safety and efficacyInfluence of multiple genes on the magnitude of the antibody response to bacterial polysaccharide antigensWanted, dead or alive: New viral vaccinesPrimary immunodeficiency for the primary care providerSecond-generation inhibitors of Bruton tyrosine kinaseEducational paper: primary antibody deficienciesAnalysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance HospitalRecurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adultsMolecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemiaDeletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA)A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male.Discordant phenotype in siblings with X-linked agammaglobulinemia.Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16qIs dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeOptimization of immunoglobulin substitution therapy by a stochastic immune response model.Conception and development of the fetal tissue bank.Comparative genomics and host resistance against infectious diseasesSignificance of the simultaneous occurrence of connective tissue disease and agammaglo-bulinaemiaIsolation of the defective gene in X linked agammaglobulinaemia.Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract InfectionsCommon variable immunodeficiency: etiological and treatment issues.Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease.Infective conjunctivitis and corneal scarring in three brothers with sex linked hypogammaglobulinaemia (Bruton's disease).Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemiaII Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.Adults with X-linked agammaglobulinemia: impact of disease on daily lives, quality of life, educational and socioeconomic status, knowledge of inheritance, and reproductive attitudes.
P2860
Q24679486-B17DF00F-2462-40E6-BC0F-D60A7F77B745Q24681549-D13F2480-0AC6-43E9-ADD7-C2777F4058B1Q24681798-CDE0C100-C10B-4DE2-BCF4-F7F877462D51Q24685932-72951544-C81A-4958-B507-0F81CFD13934Q26741124-8BF47BA4-F40D-48D6-88CF-D2E868EE1E14Q26745685-DDB9254D-2EBD-40E2-8B85-659BAEE0CDB9Q26752540-D915BB93-4BE0-4D99-8816-9332C5804D53Q26775894-3F102F56-2C0D-47E1-BF75-885DC631FCC4Q26781290-06AB12ED-A2DF-4B91-A3EA-44231A2A0033Q26784167-74262ECA-4B76-4D44-9D29-E83B9718D73AQ26859051-CDDCF9E8-4CB4-46B5-AD97-3C4A2A44EC0FQ27009322-4D0883C0-AA6C-4CCB-9686-22D542BF4633Q27027732-915DAAC0-9B29-43F0-85AB-047ADE50C35EQ27487843-06B514D8-8524-4FB4-B68A-493536C28F3BQ27489979-A607A492-C03E-4545-87E7-FDD68046744BQ28066058-1538FF47-6637-45F0-8693-3ACF4F6FAA56Q28076118-BAA579FC-8CA4-45C5-926C-967AEF22BF82Q28236790-8B40DC64-8BD7-426D-8603-5614FBB8B223Q28270557-5C8597DB-AFB5-4423-91B0-B353031EC3EDQ28362904-E0E7D3FA-57AB-4C5C-A628-1871FA7ADBA9Q30176486-C6095D37-264D-4258-B4DF-2D15904F10B6Q30194173-9FD7499E-3A97-49C1-A580-080E58E6C0DAQ30443770-7203AFBC-9CED-42C5-A504-2E8FBC38191AQ30444636-F353B84E-3186-4AD8-9E62-BABDF4AD6D36Q30454006-C02C9046-C296-48A4-A3F9-D6E12362B32FQ33228501-2C499097-437C-42BD-9485-31AD1EBE8E9AQ33419638-550EE169-34BA-4008-A1AE-53AB752FA5F9Q33455748-89660062-B335-45D2-A334-717FCEC53A2FQ33462432-181DCDFF-025B-4095-8098-C98A32AC2A79Q33542428-BE9B98B2-6486-451F-82B2-176D8C052FE5Q33571061-B2DA7498-3717-49F2-8C7F-1F2762D4BCE3Q33595409-1184587B-2D36-4552-85A6-12A976F284FCQ33603438-9D4C8ABE-6BAD-4BD7-BF80-B76BB30767EFQ33603632-8A45BDC6-901E-489C-8658-CF7669B2B74AQ33621805-CA4CD854-6704-4747-92A8-07D3A029B9E2Q33635013-87D27F3C-55C2-47CF-B20F-496E4756DA67Q33647779-DC299EDC-85E9-4769-98B9-E757B501C574Q33678961-1E91F3F3-591C-428F-864C-06DF45189F1AQ33692418-76E44A38-204F-4E0C-A8E7-E03A6B75EEF8Q33700656-1CFD4DE4-14C8-49F6-B2E8-9212D8A60AB6
P2860
description
1952 nî lūn-bûn
@nan
1952 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1952 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1952年の論文
@ja
1952年論文
@yue
1952年論文
@zh-hant
1952年論文
@zh-hk
1952年論文
@zh-mo
1952年論文
@zh-tw
1952年论文
@wuu
name
Agammaglobulinemia
@ast
Agammaglobulinemia
@en
Agammaglobulinemia
@nl
type
label
Agammaglobulinemia
@ast
Agammaglobulinemia
@en
Agammaglobulinemia
@nl
prefLabel
Agammaglobulinemia
@ast
Agammaglobulinemia
@en
Agammaglobulinemia
@nl
P3181
P1433
P1476
Agammaglobulinemia
@en
P2093
O C BRUTON
P3181
P356
10.1016/B978-012448510-5.50111-4
P407
P577
1952-06-01T00:00:00Z